David A. Bichara, MD MBA

Head of Clinical Development

Dr. David Bichara is Executive Director of Clinical Development at ReLive Biotechnologies, where he leads the company's U.S. clinical development activities and supports the broader global R&D strategy. He joined ReLive in 2022.

David is a physician-scientist with more than 17 years of experience across orthopedic medicine, academic research, and R&D leadership in biotechnology and medical devices. David has a strong background in raising Series A capital, obtaining FDA approvals, and bringing innovative technologies to market. He is known for building successful teams, ensuring smooth day-to-day operations, and creating value for startups through discovery, translational, and regulatory efforts, and business development.

Previously, David worked at Massachusetts General Hospital, Harvard Medical School as a Physician Investigator for over a decade. In 2017, he assumed the role of Director of Preclinical Development at a venture-funded synthetic cartilage startup. In 2020, he founded Noli Ventures to offer consulting services and engage in parallel entrepreneurship, aligning with industry stakeholders to create value.

David holds an MD degree from the University of Monterrey, Mexico, graduating cum laude. He completed postdoctoral fellowships at Massachusetts General Hospital, Harvard Medical School, with a focus on regenerative medicine and orthopedic biomaterials. Additionally, he earned an MBA from Boston University, US.